2030 年癫痫监测设备市场预测：按产品类型、技术、患者类型、配销通路、最终用户和地区进行的全球分析

根据 Stratistics MRC 的数据，2023 年全球癫痫监测设备市场规模为 5.567 亿美元，预计到 2030 年将达到 8.765 亿美元，预测期内年复合成长率为 6.7%。

癫痫是一种以反覆发作为特征的神经系统疾病，癫痫监测设备是医学上用于识别、追踪和管理癫痫状况的设备和技术。这些工具对于癫痫的早期检测和治疗以及改善癫痫患者的生活品质至关重要。使用这种携​​带式脑电图仪，可以在患者的日常生活中进行监测。它还涉及在大脑中植入电极以捕获抗药性癫痫患者的大脑活动。当非侵入性脑电图 (EEG) 无法提供足够的细节时，进行脑电图 (EEG)。

根据世界卫生组织（WHO）2022年2月发布的最新资讯，全球约有5000万人患有癫痫症，使其成为全球最常见的神经系统疾病之一。

患病增加

随着癫痫患者数量的增加，对癫痫监测设备的需求也增加。为了成功的疾病管理，不断增长的患者群体需要额外的诊断和监测设备。此外，随着患者数量的增加，最佳化治疗的需求也随之增加。监测设备可以帮助医疗保健专业人员为每个患者量身定制治疗方法，以便采取最佳治疗方法并提供适量的药物，并帮助政府应对不断上升的癫痫发病率。组织和医疗机构经常开展公共卫生活动。此类配合措施将提高监测和诊断服务的可及性并促进市场成长。

由于高成本而限制访问

使用癫痫监测设备可能会因成本高昂而受到阻碍，特别是对于没有足够保险或财务资源的个人而言。因此，诊断和治疗可能不充分或延迟。必须为监测设备支付高额费用的患者可能会遇到经济困难。因此，您可能无法获得所需的诊断或医疗护理。监测设备的高昂成本可能会完全阻碍其在贫穷国家等资源匮乏地区的采用，导致癫痫患者无法充分服务并阻碍市场成长。

能够改变流速并产生高压

即时资料分析、额外的监测通道和增强的讯号处理都是数位脑电图系统的标誌。高密度脑电图系统使用更多电极来记录大脑活动。这些设备提供更精确的地理资料，可以帮助定位癫痫发作的来源并更准确地描述癫痫活动。监测设备（例如穿戴式脑电图耳机）的小型化使得监测的侵入性降低且更易于使用。患者通常会发现这些设备佩戴起来更舒适且体积更小。这些进步带来了更准确的诊断、更好的患者照护和更有效的癫痫管理。

癫痫监测设备的技术复杂性

医疗保健提供者可能不愿意花钱购买需要强化培训和持续技术援助的设备，这可能会限制高度复杂的监测设备的部署。医护人员需要接受特殊训练才能操作复杂的设备和分析资料，这需要时间并导致人员短缺。监测结果的准确性和可靠性可能会因人为错误而受到影响，而技术复杂性则更有可能导致人为错误，从而导致医疗机构推迟或避免实施复杂的监测解决方案。这是有可能的。

COVID-19 的影响

癫痫监测和诊断是受疫情影响的医疗保健服务之一。包括某些诊断测试在内的选择性手术已被推迟或取消，以便为 COVID-19 患者腾出空间。这也影响了癫痫的检测和治疗方式。医疗保健负责人已开始使用远端医疗服务（例如虚拟就诊）来减少亲自就诊。远端医疗使得远距监测癫痫患者和改变治疗策略成为可能。疫情期间，癫痫患者可能会延迟接受诊断和治疗。一旦医疗服务恢復正常业务，患者可能会积压，癫痫监测的需求也会增加。

预计传统设备领域在预测期内将是最大的

由于其效率和安全性，传统设备领域预计将出现良好的成长，预计市场将由传统设备领域主导。 「常规设备」指使用脑电图（EEG）持续监测患者的设备。传统设备也常用于医院和诊所进行持续监测。专家可以使用常规技术准确诊断癫痫类型并提供最佳治疗方案。这些因素可能与持续、非侵入性癫痫监测的需求不断增加有关。市场上此类尖端产品的出现也支持了该领域的扩展。

预计深部脑部刺激领域在预测期内年复合成长率最高

由于深部脑部刺激（DBS）主要用于治疗包括帕金森氏症和自发性震颤在内的运动障碍，因此预计深部脑部刺激领域在预测期内将具有最高的年复合成长率年增长率。 DBS 也正在被研究作为癫痫治疗的一种选择，特别是在其他治疗方法失败的抗药性癫痫的情况下。儘管 DBS 不是典型的癫痫监测技术，但它确实有助于癫痫治疗的整体情况。在考虑 DBS 作为癫痫治疗方法之前，需要进行彻底的监测和评估。 EEG（脑电图）监测和视讯脑电图监测是两种类型的癫痫监测工具，用于捕捉和检查癫痫发作期间患者的大脑活动。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。美国癫痫监测设备扩张的主要要素是神经系统疾病（尤其是癫痫）的高患病以及大量的最终用户。此外，癫痫患病的增加增加了对癫痫监测设备以有效治疗患者的需求。此外，由于主要行业参与者的存在以及对产品开发和研究的大量投资，预计该领域的市场将迅速扩大。因此，由于上述方面，所研究的市场预计将在北美地区扩大。

复合年复合成长率最高的地区：

由于患病上升、对神经系统疾病的认识不断增强以及医疗技术的进步，预计亚太地区在预测期内将出现最高的年复合成长率。在医疗环境中使用癫痫监测设备进行长期视讯脑电图监测。此外，还创建了几种可以在家中使用的小工具，让患者更容易监测自己的健康状况。由于人们对癫痫及相关疾病的认识不断提高以及医疗保健系统的发展，监测设备的使用越来越多。在医疗保健系统迅速扩张的国家尤其如此。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

• 公司简介
  • 其他市场参与者的综合分析（最多 3 家公司）
  • 主要企业SWOT分析（最多3家企业）
• 区域分割
  • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
• 竞争基准化分析
  • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

• 概述
• 利害关係人
• 调查范围
• 调查方法
  • 资料探勘
  • 资料分析
  • 资料检验
  • 研究途径
• 调查来源
  • 主要调查来源
  • 二次调查来源
  • 先决条件

第3章市场趋势分析

• 促进因素
• 抑制因素
• 机会
• 威胁
• 产品分析
• 技术分析
• 最终用户分析
• 新兴市场
• 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

• 供应商的议价能力
• 买方议价能力
• 替代的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第5章全球癫痫监测设备市场：依产品

• 常规设备
  • 监控装置
    • 脑电图（EEG）设备
    • 标准脑电图 (EEG) 设备
    • 视讯脑电图 (EEG) 设备
    • 其他/手提脑电图仪
    • 肌电图 (EMG) 设备
    • 磁脑造影 (MEG) 设备
    • 其他监控设备
  • 深层脑部刺激器
• 穿戴式装置

第6章全球癫痫监测设备市场：按类型

• 全身性癫痫发作
• 局部癫痫发作

第7章全球癫痫监测设备市场：依技术分类

• 脑深部刺激
• 加速计
• 反应性神经刺激
• 迷走神经刺激
• 其他技术

第8章全球癫痫监测设备市场：依患者类型

• 对于老年人
• 成人
• 儿童

第9章全球癫痫监测设备市场：依配销通路

• 网上销售
• 零售销售
• 直接竞标
• 其他配销通路

第10章全球癫痫监测设备市场：依最终用户分类

• 医院
• 门诊服务
• 神经中枢
• 诊断中心
• 其他最终用户

第11章全球癫痫监测设备市场：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 其他欧洲国家
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 卡达
  • 南非
  • 其他中东和非洲

第12章进展

• 合约、伙伴关係、协作和合资企业
• 收购和合併
• 新产品发布
• 业务扩展
• 其他关键策略

第13章公司简介

• Abbott Laboratories
• Bioserenity
• Boston Scientific Corporation
• Brain Sentinel Inc.
• Cadwell industries
• Compumedics USA inc
• Emfit Corporation
• Empatica Inc
• Epilert
• General Electric company
• Kninklijke Philips NV
• Masimo
• Medpage Ltd
• Medtronic
• Natus Medical Incorporated
• Neurosoft
• Neurowave systems
• Nihon Kohden Corporation
• Nonin
• Pulse Guard International Ltd.

According to Stratistics MRC, the Global Epilepsy Monitoring Devices Market is accounted for $556.7 million in 2023 and is expected to reach $876.5 million by 2030 growing at a CAGR of 6.7% during the forecast period. Epilepsy is a neurological ailment marked by recurring seizures, and epilepsy monitoring devices are instruments and technology used in medicine to identify, track, and manage the condition. These tools are essential for the early detection and management of epilepsy, as well as for enhancing the quality of life for those who have the condition. With the help of this portable EEG gadget, patients may be monitored while going about their daily business. It aids in catching seizures that might not happen while you're in the hospital and it includes implanting electrodes into the brain to capture brain activity in people with drug-resistant epilepsy. When non-invasive EEG techniques don't yield enough details, it's employed.

According to the World Health Organization's February 2022 update, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.

Market Dynamics:

Driver:

Growing prevalence of epilepsy

The need for epilepsy monitoring equipment grows along with the number of people who have the condition. To successfully manage their illness, a growing patient population needs additional diagnostic and monitoring instruments. Moreover, the need for therapy optimization results from a growing patient population. In order to ensure that the best therapies are employed and that the correct quantities of pharmaceuticals are provided, monitoring devices assist healthcare providers in customizing treatment regimens to each patient and combat the rising frequency of epilepsy, governmental organizations and medical institutions frequently develop public health campaigns. These initiatives can concentrate on enhancing accessibility to monitoring and diagnosing services thus propel the market growth.

Restraint:

Limited access due to high cost

Access to epilepsy monitoring equipment may be hampered by high expenses, especially for individuals without sufficient insurance or financial resources. This may result in inadequate or delayed diagnosis and care. Patients who are required to pay a substantial amount of the cost of monitoring equipment could experience financial difficulties. This can deter individuals from getting the essential diagnostic procedures or medical care. The expensive expense of monitoring equipment may completely prohibit their adoption in areas with little resources, such as poor nations, leaving people with epilepsy underserved thus hamper the market growth.

Opportunity:

Ability to change flow rates and reach high pressure

Real-time data analysis, additional monitoring channels, and enhanced signal processing are all features of digital EEG systems. More electrodes are used in high-density EEG systems to record brain activity. These devices offer more precise geographical data, which is useful for locating the source of seizures and more accurately describing epileptic activity. Monitoring has become less obtrusive and more user-friendly because to the miniaturization of monitoring equipment, such as wearable EEG headsets. Patients typically find these gadgets to be more comfortable and less bulky to wear. Together, these developments lead to more precise diagnoses, better patient care, and more effective management of epilepsy.

Threat:

Technical complexity of epilepsy monitoring devices

The adoption of very complicated monitoring devices can be constrained because healthcare providers might be reluctant to spend money on equipment that needs intensive training and continuing technical assistance. To operate and analyze data from complicated equipment, healthcare personnel require specific training and result in lengthy training times and a staffing scarcity. The accuracy and dependability of monitoring findings may be jeopardized by human mistakes, which are made more likely by technical complexity and healthcare institutions may postpone or avoid deploying complicated monitoring solutions.

COVID-19 Impact

Epilepsy monitoring and diagnosis were among the healthcare services that were disrupted by the epidemic. In order to make room for COVID-19 patients, elective procedures including certain diagnostic tests were postponed or cancelled. This had an effect on how epilepsy was identified and treated. Healthcare practitioners started using telehealth services, such as virtual consultations, to reduce in-person visits. Telehealth made it possible to remotely monitor epilepsy patients and modify treatment strategies; often negating the need for physical monitoring equipment. During the pandemic, patients with epilepsy may have had delays in seeking a diagnosis or treatment. Once healthcare services resume regular operations, this might result in a backlog of patients and increased need for epilepsy monitoring.

The conventional devices segment is expected to be the largest during the forecast period

The conventional devices segment is estimated to have a lucrative growth, due to its efficiency and safety, the market is projected to be dominated by the traditional devices segment. The term "conventional devices" refers to equipment used to continuously monitor patients using electroencephalograms (EEG). Conventional equipment is also commonly utilized in hospitals and clinics for on-going monitoring. Professionals can accurately diagnose the kind of seizure to provide the best course of therapy using conventional technology. These elements can be linked to the rising need for continuous, non-invasive epilepsy monitoring. The availability of such cutting-edge items on the market also aids in the segment's expansion.

The deep brain stimulation segment is expected to have the highest CAGR during the forecast period

The deep brain stimulation segment is anticipated to witness the highest CAGR growth during the forecast period, as deep brain stimulation (DBS) has been mainly employed to treat movement disorders including Parkinson's disease and essential tremor. It has also been investigated as a possible epileptic therapy option, particularly in situations of drug-resistant epilepsy where other therapies have failed. Although DBS is not a typical epilepsy monitoring technology, it does contribute to the overall picture of epilepsy therapy. A thorough monitoring and assessment are required before contemplating DBS as a therapy for epilepsy. EEG (electroencephalogram) and video-EEG monitoring are two types of epilepsy monitoring tools used to capture and examine a patient's brain activity during seizures.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the main drivers of the expansion of epilepsy monitoring devices in the United States are the high prevalence of neurological illnesses, particularly epilepsy, and the sheer volume of end users. Moreover, due to the rising prevalence of epilepsy, there is an increased need for epilepsy monitoring equipment in order to treat patients effectively. Additionally, it is anticipated that the market in this area would expand faster due to the presence of the key industry players there and their heavy investment in product development and research. The studied market is therefore anticipated to increase in the North American area as a result of the aforementioned aspects.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the rising epilepsy prevalence, rising awareness of neurological diseases, and improvements in medical technology. Long-term video-EEG monitoring with epilepsy monitoring equipment has been done in medical settings. Additionally, several gadgets were made to be used at home, making it easier for patients to keep an eye on their health. Monitoring devices were used as a result of rising epilepsy and associated condition awareness as well as the development of the healthcare system. This was especially true in nations with healthcare systems that were expanding quickly.

Key players in the market

Some of the key players profiled in the Epilepsy Monitoring Devices Market include: Abbott Laboratories, Bioserenity, Boston Scientific Corporation, Brain Sentinel Inc., Cadwell industries, Compumedics USA inc, Emfit Corporation, Empatica Inc, Epilert, General Electric company, Kninklijke Philips N.V., Masimo, Medpage Ltd, Medtronic, Natus Medical Incorporated, Neurosoft, Neurowave systems, Nihon Kohden Corporation, Nonin and Pulse Guard International Ltd.

Key Developments:

In September 2023, Abbott announced that it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

In August 2023, Cadwell Launches Sierra NMUS1 Ultrasound and Sierra 4 Software. The new Sierra NMUS1 offers high-resolution neuromuscular and musculoskeletal ultrasound, and needle guidance capabilities, with integrated controls.

Products Covered:

• Conventional Devices
• Wearable Devices

Types Covered:

• Generalized Seizures
• Focal Seizures

Technologies Covered:

• Deep Brain Stimulation
• Accelometry
• Responsive Neurostimulation
• Vagus Nerve Stimulation
• Other Technologies

Patient Types Covered:

• Geriatric
• Adults
• Paediatric

Distribution Channels Covered:

• Online Sales
• Retail Sales
• Direct Tenders
• Other Distribution Channels

End Users Covered:

• Hospitals
• Ambulatory Services
• Neurology Centers
• Diagnostic Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Epilepsy Monitoring Devices Market, By Product

• 5.1 Introduction
• 5.2 Conventional Devices
  • 5.2.1 Monitoring Devices
    • 5.2.1.1 Electroencephalogram (EEG) Devices
    • 5.2.1.1.1 Standard Electroencephalogram (EEG) Devices
    • 5.2.1.1.2 Video Electroencephalogram (EEG) Devices
    • 5.2.1.1.3 Other/Ambulatory EEG Devices
    • 5.2.1.2 Electromyography (EMG) Devices
    • 5.2.1.3 Magnetoencphalography (MEG) Devices
    • 5.2.1.4 Other Monitoring Devices
  • 5.2.2 Deep Brain Stimulation Devices
• 5.3 Wearable Devices

6 Global Epilepsy Monitoring Devices Market, By Type

• 6.1 Introduction
• 6.2 Generalized Seizures
• 6.3 Focal Seizures

7 Global Epilepsy Monitoring Devices Market, By Technology

• 7.1 Introduction
• 7.2 Deep Brain Stimulation
• 7.3 Accelometry
• 7.4 Responsive Neurostimulation
• 7.5 Vagus Nerve Stimulation
• 7.6 Other Technologies

8 Global Epilepsy Monitoring Devices Market, By Patient Type

• 8.1 Introduction
• 8.2 Geriatric
• 8.3 Adults
• 8.4 Paediatric

9 Global Epilepsy Monitoring Devices Market, By Distribution Channel

• 9.1 Introduction
• 9.2 Online Sales
• 9.3 Retail Sales
• 9.4 Direct Tenders
• 9.5 Other Distribution Channels

10 Global Epilepsy Monitoring Devices Market, By End User

• 10.1 Introduction
• 10.2 Hospitals
• 10.3 Ambulatory Services
• 10.4 Neurology Centers
• 10.5 Diagnostic Centers
• 10.6 Other End Users

11 Global Epilepsy Monitoring Devices Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Abbott Laboratories
• 13.2 Bioserenity
• 13.3 Boston Scientific Corporation
• 13.4 Brain Sentinel Inc.
• 13.5 Cadwell industries
• 13.6 Compumedics USA inc
• 13.7 Emfit Corporation
• 13.8 Empatica Inc
• 13.9 Epilert
• 13.10 General Electric company
• 13.11 Kninklijke Philips N.V.
• 13.12 Masimo
• 13.13 Medpage Ltd
• 13.14 Medtronic
• 13.15 Natus Medical Incorporated
• 13.16 Neurosoft
• 13.17 Neurowave systems
• 13.18 Nihon Kohden Corporation
• 13.19 Nonin
• 13.20 Pulse Guard International Ltd.

List of Tables

• Table 1 Global Epilepsy Monitoring Devices Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Epilepsy Monitoring Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Epilepsy Monitoring Devices Market Outlook, By Conventional Devices (2021-2030) ($MN)
• Table 4 Global Epilepsy Monitoring Devices Market Outlook, By Monitoring Devices (2021-2030) ($MN)
• Table 5 Global Epilepsy Monitoring Devices Market Outlook, By Electroencephalogram (EEG) Devices (2021-2030) ($MN)
• Table 6 Global Epilepsy Monitoring Devices Market Outlook, By Standard Electroencephalogram (EEG) Devices (2021-2030) ($MN)
• Table 7 Global Epilepsy Monitoring Devices Market Outlook, By Video Electroencephalogram (EEG) Devices (2021-2030) ($MN)
• Table 8 Global Epilepsy Monitoring Devices Market Outlook, By Other/Ambulatory EEG Devices (2021-2030) ($MN)
• Table 9 Global Epilepsy Monitoring Devices Market Outlook, By Electromyography (EMG) Devices (2021-2030) ($MN)
• Table 10 Global Epilepsy Monitoring Devices Market Outlook, By Magnetoencphalography (MEG) devices (2021-2030) ($MN)
• Table 11 Global Epilepsy Monitoring Devices Market Outlook, By Other Monitoring Devices (2021-2030) ($MN)
• Table 12 Global Epilepsy Monitoring Devices Market Outlook, By Deep Brain Stimulation Devices (2021-2030) ($MN)
• Table 13 Global Epilepsy Monitoring Devices Market Outlook, By Wearable Devices (2021-2030) ($MN)
• Table 14 Global Epilepsy Monitoring Devices Market Outlook, By Type (2021-2030) ($MN)
• Table 15 Global Epilepsy Monitoring Devices Market Outlook, By Generalized Seizures (2021-2030) ($MN)
• Table 16 Global Epilepsy Monitoring Devices Market Outlook, By Focal Seizures (2021-2030) ($MN)
• Table 17 Global Epilepsy Monitoring Devices Market Outlook, By Technology (2021-2030) ($MN)
• Table 18 Global Epilepsy Monitoring Devices Market Outlook, By Deep Brain Stimulation (2021-2030) ($MN)
• Table 19 Global Epilepsy Monitoring Devices Market Outlook, By Accelometry (2021-2030) ($MN)
• Table 20 Global Epilepsy Monitoring Devices Market Outlook, By Responsive Neurostimulation (2021-2030) ($MN)
• Table 21 Global Epilepsy Monitoring Devices Market Outlook, By Vagus Nerve Stimulation (2021-2030) ($MN)
• Table 22 Global Epilepsy Monitoring Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 23 Global Epilepsy Monitoring Devices Market Outlook, By Patient Type (2021-2030) ($MN)
• Table 24 Global Epilepsy Monitoring Devices Market Outlook, By Geriatric (2021-2030) ($MN)
• Table 25 Global Epilepsy Monitoring Devices Market Outlook, By Adults (2021-2030) ($MN)
• Table 26 Global Epilepsy Monitoring Devices Market Outlook, By Paediatric (2021-2030) ($MN)
• Table 27 Global Epilepsy Monitoring Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 28 Global Epilepsy Monitoring Devices Market Outlook, By Online Sales (2021-2030) ($MN)
• Table 29 Global Epilepsy Monitoring Devices Market Outlook, By Retail Sales (2021-2030) ($MN)
• Table 30 Global Epilepsy Monitoring Devices Market Outlook, By Direct Tenders (2021-2030) ($MN)
• Table 31 Global Epilepsy Monitoring Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
• Table 32 Global Epilepsy Monitoring Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 33 Global Epilepsy Monitoring Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 34 Global Epilepsy Monitoring Devices Market Outlook, By Ambulatory Services (2021-2030) ($MN)
• Table 35 Global Epilepsy Monitoring Devices Market Outlook, By Neurology Centers (2021-2030) ($MN)
• Table 36 Global Epilepsy Monitoring Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 37 Global Epilepsy Monitoring Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.